SHANGHAI, Sept. 29, 2025 -- Smartee Denti-Technology today announced that Professor Gang Shen, its Chief Scientist and Executive President of TaiKang ByBo Dental, has once again been named to the World's Top 2% Scientists list, compiled by Stanford University in partnership with Elsevier. This marks the third consecutive year Prof. Shen has earned this prestigious recognition. Notably, he was honored in both the Career-Long Impact and Single-Year Impact categories, highlighting his long-term global impact and pioneering contributions to orthodontics.

Now in its eighth edition, the World's Top 2% Scientists list draws on Scopus data from 1960 to 2024, evaluating over 200,000 scientists worldwide across 22 scientific fields and 174 subfields. It identifies the world's most influential researchers shaping scientific advancement and innovation.

With more than three decades dedicated to orthodontic research, clinical practice, and innovation, Prof. Shen has made transformative contributions to the discipline. Among his key academic achievements is the development of a facial morphology–based classification system for malocclusion, categorizing cases into facial convexity, facial concavity, and mandibular deviation. This novel framework represents an important evolution beyond the traditional Angle's classification system. It not only provides an accurate diagnostic framework for complex malocclusions but also delivers critical insights into their etiolgoy, along with specific treatment modalities to each category.

In 2019, Prof. Shen began a strategic collaboration with Smartee Denti-Technology, translating decades of foundational research into clinical application. This partnership led to the development of the Smartee GS clear aligner series, built on an innovative clear mandibular repositioning technology co-developed by Prof. Shen and Smartee. The GS system has revolutionized the treatment for skeletal Class II and Class III malocclusions by introducing a non-invasive approach that minimize the need for tooth extraction. The breakthrough has significantly expanded the scope of clear aligner therapy, redefining the boundaries of digital orthodontics. To date, its clinical validity is demonstrated in over 100,000 cases worldwide.

Looking ahead, Prof. Shen and Smartee remain committed to advancing orthodontic science, tackling critical challenges in clinical practice, and driving independent innovation in core technologies. Together, they aim to bridge academic research with real-world application, delivering next-generation orthodontic solutions that improve patient outcomes across the globe.